Cost Of FDA Reforms Is Big Challenge For ‘Cures’ Legislation

Drug industry warns that unfunded mandates in the 21st Century Cures discussion document could impact FDA’s ability to focus on drug reviews; Energy and Commerce legislators are working to get appropriators on board.